Reportable Diseases & Conditions
For Providers, Report the Following Conditions:
(Per Health-General 18-201 and 18-202, and Code of Maryland Regulations 10.06.01 Communicable Diseases)
- Any outbreak of disease/bioterrorism event with known or unknown etiology that may be a public health danger
- Any single case of disease/bioterrorism event with known or unknown etiology that may be a public health danger
- Any unusual manifestation of a communicable disease
List of Diseases and Conditions
- â–º = Report Immediately by Telephone
- Report all others within 1 working day
| Acquired Immunodeficiency Syndrome (AIDS) | Malaria |
| Amebiasis | â–ºMeasles (Rubeola) |
| Anaplasmosis | â–ºMelioidosis |
| â–ºAnimal bites | Meningitis, infectious |
| â–ºAnthrax | â–ºMeningococcal, invasive disease |
| Arboviral infections | Microsporidiosis |
| Babesiosis | Mumps (infectious parotitis) |
| â–ºBotulism | Mycobacteriosis, other than Tuberculosis and Leprosy |
| â–ºBrucellosis | â–ºPertussis |
| Campylobacteriosis | Pertussisvaccine adverse reactions |
| Chancroid | Pesticide related illness |
| Chlamydia infection | â–ºPlague |
| â–ºCholera | Pneumonia in a hospitalized health care worker |
| Coccidioidomycosis | â–ºPoliomyelitis |
| Creutzfeldt-Jakob disease | Psittacosis |
| Cryptosporidiosis | â–ºQ fever |
| Cyclosporiasis | â–ºRabies (human) |
| â–ºDiphtheria | â–ºRicin toxin poisoning |
| Ehrlichiosis | Rocky Mountain SpottedFever |
| Encephalitis, infectious | â–ºRubella (German measles) and Congenital Rubella Syndrome |
| â–ºEpsilon toxin of Clostridium perfringens | Salmonellosis (nontyphoidal) |
| â–ºEscherichia coli 0157:H7 infection | â–ºSARS (Severe Acute Respiratory Syndrome) |
| Giardiasis | â–ºShiga-like toxin producing enteric bacterial infections |
| â–ºGlanders | Shigellosis |
| Gonococcal infection | â–ºSmallpox and other Orthopoxvirus infections |
| â–ºHaemophilus influenzae, invasive disease | â–ºStaphylococcal enterotoxin B poisoning |
| â–ºHantavirus infection | Streptococcal invasive disease, Group A and Group B |
| Harmful Algal Bloom related illness | Streptococcus pneumoniae, invasive disease |
| Hemolytic uremic syndrome, post-diarrheal | Syphilis |
| Hepatitis, viral (â–ºA,B,C, all other types and undetermined) | Tetanus |
| Human Immunodeficiency Virus (HIV) | Trichinosis |
| Influenza-associated pediatric mortality | â–ºTuberculosis and suspected tuberculosis |
| â–ºInfluenza: novel influenza A virus infection | â–ºTularemia |
| Isosporiasis | â–ºTyphoid fever (Salmonella typhi case, carrier, or both) |
| Kawasaki syndrome | Vancomycin-Intermediate Staphylococcus Aureus (VISA) infection or colonization |
| â–ºLegionellosis | Vancomycin-Resistant Staphylococcus Aureus (VRSA ) infection or colonization |
| Leprosy | Varicella (chickenpox), fatal cases only |
| Leptospirosis | Vibriosis, non-cholera types |
| Listeriosis | â–ºViral hemorrhagic fevers (all types) |
| Lyme disease | Yersiniosis |
Contact Us
Communicable Disease/Vector-Borne Disease Control
-
3003 Hospital Drive
Suite 1066
Cheverly, MD 20785
United States